Division of Plastic Surgery, Department of Surgery, University of Pennsylvania Health System, 51 North 39th Street, Wright Saunders Building, Philadelphia, PA, 19104, USA.
Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
Hernia. 2022 Oct;26(5):1355-1368. doi: 10.1007/s10029-022-02644-4. Epub 2022 Aug 25.
It is unknown whether the trend of rising incisional hernia (IH) repair (IHR) incidence and costs until 2011 currently persists. We aimed to evaluate how the IHR procedure incidence, cost and patient risk-profile have changed over the last decade relative to all abdominal surgeries (AS).
Repeated cross-sectional analysis of 38,512,737 patients undergoing inpatient 4AS including IHR within the 2008-2018 National Inpatient Sample. Yearly incidence (procedures/1,000,000 people [PMP]), hospital costs, surgical and patient characteristics were compared between IHR and AS using generalized linear and multinomial regression.
Between 2008-2018, 3.1% of AS were IHR (1,200,568/38,512,737). There was a steeper decrease in the incidence of AS (356.5 PMP/year) compared to IHR procedures (12.0 PMP/year) which resulted in the IHR burden relative to AS (2008-2018: 12,576.3 to 9,113.4 PMP; trend difference P < 0.01). National costs averaged $47.9 and 1.7 billion/year for AS and IHR, respectively. From 2008-2018, procedure costs increased significantly for AS (68.2%) and IHR (74.6%; trends P < 0.01). Open IHR downtrended (42.2%), whereas laparoscopic (511.1%) and robotic (19,301%) uptrended significantly (trends P < 0.01). For both AS and IHR, the proportion of older (65-85y), Black and Hispanic, publicly-insured, and low-income patients, with higher comorbidity burden, undergoing elective procedures at small- and medium-sized hospitals uptrended significantly (all P < 0.01).
IH persists as a healthcare burden as demonstrated by the increased proportion of IHR relative to all AS, disproportionate presence of high-risk patients that undergo these procedures, and increased costs. Targeted efforts for IH prevention have the potential of decreasing $17 M/year in costs for every 1% reduction.
目前尚不清楚直到 2011 年为止,切口疝(IH)修复(IHR)发病率和成本上升的趋势是否持续。我们旨在评估过去十年中,与所有腹部手术(AS)相比,IHR 手术的发病率、成本和患者风险状况发生了怎样的变化。
使用广义线性和多项回归,对 2008-2018 年全国住院患者样本中 38512737 例接受住院 4AS(包括 IHR)的患者进行了 38512737 例患者的重复横截面分析。使用广义线性和多项回归,比较了 IHR 和 AS 之间每年的发病率(每 100 万人[PMP]的手术程序)、医院成本、手术和患者特征。
在 2008-2018 年期间,3.1%的 AS 为 IHR(1200568/38512737)。AS 的发病率下降幅度较大(356.5 PMP/年),而 IHR 手术的发病率下降幅度较小(12.0 PMP/年),这导致 IHR 相对于 AS 的负担增加(2008-2018 年:12576.3 至 9113.4 PMP;趋势差异 P < 0.01)。AS 和 IHR 的国家平均成本分别为 47.9 亿美元和 170 亿美元/年。从 2008 年至 2018 年,AS 和 IHR 的手术费用分别显著增加(68.2%和 74.6%;趋势 P < 0.01)。开放式 IHR 呈下降趋势(42.2%),而腹腔镜(511.1%)和机器人(19301%)呈显著上升趋势(趋势 P < 0.01)。对于 AS 和 IHR,年龄在 65-85 岁、黑人、西班牙裔、公保和低收入患者的比例,以及具有更高合并症负担的择期手术患者的比例均显著上升(所有 P < 0.01)。
IH 仍然是医疗保健的负担,这表现在 IHR 相对于所有 AS 的比例增加,高风险患者进行这些手术的比例不成比例,以及成本增加。针对 IH 预防的有针对性的努力有可能使每年每降低 1%的费用减少 1700 万美元。